Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Lapatinib (L01Eh01) As Part Of A So-Called Open House Model.

AOK RHEINLAND-PFALZ SAARLAND - DIE GESUNDHEITSKASSE Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Lapatinib (L01Eh01) As Part Of A So-Called Open House Model. in Healthcare and Medicine. The tender was released on Jun 13, 2023.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Lapatinib (L01Eh01) As Part Of A So-Called Open House Model.

Deadline - May 31, 2025

GT reference number - 67443130

Product classification - Medical equipments, pharmaceuticals and personal care products